LISKOVA, A., M. SAMEC, L. KOKLESOVA, S. M. SAMUELSM, K. V. ZHAI, R. K. AL-ISHAQ, M. ABOTALEB, V. NOSAL, K. KAJO, M. ASHRAFIZADEH, A. ZARRABI, A. BROCKMUELLER, M. SHAKIBAEI, P. SABAKA, I. MOZOS, D. ULLRICH, Robert PROSECKÝ, G. LA ROCCA, M. CAPRNDA, D. BUSSELBERG, L. RODRIGO, Peter KRUŽLIAK a P. KUBATKA. Flavonoids against the SARS-CoV-2 induced inflammatory storm. BIOMEDICINE & PHARMACOTHERAPY. Paris: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2021, roč. 138, June 2021, s. 1-12. ISSN 0753-3322. Dostupné z: https://dx.doi.org/10.1016/j.biopha.2021.111430.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Flavonoids against the SARS-CoV-2 induced inflammatory storm
Autoři LISKOVA, A., M. SAMEC, L. KOKLESOVA (203 Česká republika), S. M. SAMUELSM, K. V. ZHAI, R. K. AL-ISHAQ, M. ABOTALEB, V. NOSAL, K. KAJO, M. ASHRAFIZADEH, A. ZARRABI, A. BROCKMUELLER, M. SHAKIBAEI, P. SABAKA, I. MOZOS, D. ULLRICH, Robert PROSECKÝ (203 Česká republika, domácí), G. LA ROCCA, M. CAPRNDA, D. BUSSELBERG, L. RODRIGO, Peter KRUŽLIAK (703 Slovensko, garant, domácí) a P. KUBATKA.
Vydání BIOMEDICINE & PHARMACOTHERAPY, Paris, ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2021, 0753-3322.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Francie
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 7.419
Kód RIV RIV/00216224:14110/21:00123995
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.biopha.2021.111430
UT WoS 000641386500004
Klíčová slova anglicky SARS-CoV-2; COVID-19; Inflammation; Cytokine storm; Phytochemicals; Flavonoids; Immunomodulation; Anti-inflammatory effects
Štítky 14110116, 14110121, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 31. 1. 2022 10:08.
Anotace
The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out by the regulation of inflammatory mediators, the inhibition of endothelial activation, NLRP3 inflammasome, toll-like receptors (TLRs) or bromodomain containing protein 4 (BRD4), and the activation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2), might be beneficial in regulating the cytokine storm during SARS-CoV-2 infection. Moreover, the ability of flavonoids to inhibit dipeptidyl peptidase 4 (DPP4), neutralize 3-chymotrypsin-like protease (3CL(pro)) or to affect gut microbiota to maintain immune response, and the dual action of angiotensin-converting enzyme 2 (ACE-2) may potentially also be applied to the exaggerated inflammatory responses induced by SARS-CoV-2. Based on the previously proven effects of flavonoids in other diseases or on the basis of newly published studies associated with COVID-19 (bioinformatics, molecular docking), it is reasonable to assume positive effects of flavonoids on inflammatory changes associated with COVID-19. This review highlights the current state of knowledge of the utility of
VytisknoutZobrazeno: 19. 7. 2024 08:13